Flagship Ventures Management
Latest statistics and disclosures from Flagship Pioneering's latest quarterly 13F-HR filing:
Tip: Access up to 7 years of quarterly data
Positions held by Flagship Ventures Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 5 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Generate Biomedicines Com Shs (GENB) | 68.7 | $1.1B | 63M | 16.87 |
|
|
| Moderna (MRNA) | 21.1 | $324M | 4.6M | 70.03 |
|
|
| Sana Biotechnology (SANA) | 5.7 | $87M | 25M | 3.49 |
|
|
| Foghorn Therapeutics (FHTX) | 4.0 | $62M | 13M | 4.88 |
|
|
| Seres Therapeutics Com New (MCRB) | 0.6 | $9.1M | 1.2M | 7.89 |
|
Past Filings by Flagship Pioneering
SEC 13F filings are viewable for Flagship Pioneering going back to 2016
- Flagship Pioneering 2026 Q2 filed Aug. 14, 2026
- Flagship Pioneering 2026 Q1 filed May 15, 2026
- Flagship Pioneering 2025 Q4 filed Feb. 17, 2026
- Flagship Pioneering 2025 Q3 filed Nov. 14, 2025
- Flagship Pioneering 2025 Q2 filed Aug. 14, 2025
- Flagship Pioneering 2025 Q1 filed May 15, 2025
- Flagship Pioneering 2024 Q4 filed Feb. 14, 2025
- Flagship Pioneering 2024 Q3 filed Nov. 14, 2024
- Flagship Pioneering 2024 Q2 filed Aug. 14, 2024
- Flagship Pioneering 2024 Q1 filed May 15, 2024
- Flagship Pioneering 2023 Q4 filed Feb. 14, 2024
- Flagship Pioneering 2023 Q3 filed Nov. 14, 2023
- Flagship Pioneering 2023 Q2 filed Aug. 14, 2023
- Flagship Pioneering 2023 Q1 filed May 15, 2023
- Flagship Pioneering 2022 Q4 filed Feb. 14, 2023
- Flagship Pioneering 2022 Q3 filed Nov. 14, 2022